martes, 5 de septiembre de 2017

Prostate Cancer Awareness Month Search | National Guideline Clearinghouse

Search | National Guideline Clearinghouse
ngc



  • GUIDELINE SUMMARY
  •    
  • NGC:009101
  •    
  • 1996 (REVISED 2012 JUL 17)

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

  • GUIDELINE SUMMARY
  •    
  • NGC:009352
  •    
  • 2004 MAY (REVISED 2012 OCT)

Cancer screening.

  • GUIDELINE SUMMARY
  •    
  • NGC:009206
  •    
  • 2011 JUL (REVISED 2012 JAN)

Care of the HIV-infected transgender patient.

  • GUIDELINE SUMMARY
  •    
  • NGC:010672
  •    
  • 1996 (REVISED 2014)

ACR Appropriateness Criteria® non-spine bone metastases.

  • GUIDELINE SUMMARY
  •    
  • NGC:011222
  •    
  • 2017 MAY 20

Brachytherapy for patients with prostate cancer: American Society of Clinical Oncology/Cancer Care Ontario joint guideline update.

  • GUIDELINE SUMMARY
  •    
  • NGC:011153
  •    
  • 2016

ACR Appropriateness Criteria® prostate cancer—pretreatment detection, surveillance, and staging.

  • GUIDELINE SUMMARY
  •    
  • NGC:010961
  •    
  • 2016 APR 27

Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated.

  • GUIDELINE SUMMARY
  •    
  • NGC:010892
  •    
  • 2016 JAN 27

Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases.

  • GUIDELINE SUMMARY
  •    
  • NGC:009907
  •    
  • 2013 APR

Adjuvant and salvage radiotherapy after prostatectomy: ASTRO/AUA guideline.

  • GUIDELINE SUMMARY
  •    
  • NGC:010205
  •    
  • 2008 FEB (REVISED 2014 JAN)

Prostate cancer: diagnosis and treatment.

  • GUIDELINE SUMMARY
  •    
  • NGC:010470
  •    
  • 1996 (REVISED 2014)

ACR Appropriateness Criteria® postradical prostatectomy irradiation in prostate cancer.

  • GUIDELINE SUMMARY
  •    
  • NGC:010893
  •    
  • 2016 JAN 27

Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated.

  • GUIDELINE SUMMARY
  •    
  • NGC:010722
  •    
  • 2015 JUN 2

Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index.

  • GUIDELINE SUMMARY
  •    
  • NGC:010730
  •    
  • 2013 APR (REVISED 2015 APR)

Castration-resistant prostate cancer: AUA guideline.

  • GUIDELINE SUMMARY
  •    
  • NGC:010731
  •    
  • 2010 MAY (REVISED 2015 JUN)

Lower urinary tract symptoms in men: assessment and management.

  • GUIDELINE SUMMARY
  •    
  • NGC:011100
  •    
  • 2016 SEP 23

Bone health and bone-targeted therapies for prostate cancer.

  • GUIDELINE SUMMARY
  •    
  • NGC:010592
  •    
  • 1994 JUN (REVISED 2014 NOV 4)

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

  • GUIDELINE SUMMARY
  •    
  • NGC:010623
  •    
  • 2014 OCT 20

Systemic therapy in men with metastatic castration-resistant prostate cancer: American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline.

  • GUIDELINE SUMMARY
  •    
  • NGC:010181
  •    
  • 1996 (REVISED 2013)

ACR Appropriateness Criteria® definitive external-beam irradiation in stage T1 and T2 prostate cancer.

  • GUIDELINE SUMMARY
  •    
  • NGC:009823
  •    
  • 2013 MAY 21

Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.

No hay comentarios: